Giovanni Luca Frassineti
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Gastric Cancer Management and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics
Most-Cited Works
- → Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial(2020)314 cited
- → A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum(1998)289 cited
- → Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma(2024)268 cited
- → Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs(2013)220 cited
- → Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?(2018)186 cited